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Here, the proteolytic processing of the Semiiki Forest virus (SFV) capsid protein was studied in the absence 
of other viral functions. Two different fragments of the SFV messenger cDNA, coding for capsid protein 
and 174 and 38 extra amino acids from the envelope proteins, respectively, were cloned in the late region 
of the SV40 viral DNA. Cells infected with the SV40 recombinant virus stocks were analyzed for the produc- 
tion of SFV capsid mRNA and poiypeptide. Immunofluore~n~ staining of the infected ceils indicated 
that the produced SFV capsid protein accumulated mainly in the nucleus. Polyacrylamide g l electrophore- 
sis of the immunoprecipitated SFV capsid proteins showed that both recombinants yielded a labelled band 
equivalent insize to the SFV capsid protein. Thus the proteoiytic processing takes place even under condi- 
tions where the capsid protein is the only virus-specified protein synthesized. 
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1. INTRODUCTION 
Semliki Forest virus (SFV) has a single-stranded 
genome (42 S RNA) of 11454 nucleotides. The 
genome itself serves as a messenger for 4 non- 
structural proteins, which are translated as a 
polyprotein [1,2]. A subgenomic RNA, the 26 S 
RNA, serves as a messenger for the 4 structural 
proteins, which are also formed by proteolytic pro- 
cessing of a common precursor. In this latter 
pol~rotein, the hydrophilic capsid protein, which 
remains in the cytoplasm, is N-terminal followed 
by the 3 membrane proteins E3’, E2 and El in that 
order [3,4]. The capsid protein is cleaved from the 
nascent polypeptide. This is a prerequisite for the 
transport of the membrane proteins to the cell sur- 
face [5]. The cleavage of the capsid protein must 
consequently be fast, efficient and accurate. 
Aliperti and Schlesinger [6] have suggested that the 
cleavage is catalyzed by either the capsid protein 
itself or by a ribosomal protease. The wide host 
range of the SFV, in vitro translation assays [7] 
and the existence of a viral mutant with the 
cleavage blocked under restrictive temperature [S] 
suggest that the cleavage is a virus-coded function. 
The virus replicates in the cytoplasm causing an 
efficient inhibition of the host cell protein syn- 
thesis [I]. The capsid protein may well play a role 
in this inhibition [9-l 11. Pulse-chase studies in 
SFV infected cells have shown that the newly syn- 
thesized capsid protein first associates with the 
large ribosomal subunit and then with the viral 
42 S RNA genome to form nucleocapsids [12]. 
Here, the expression and cleavage of the capsid 
from a truncated polyprotein were investigated in 
the absence of other SFV functions. The cDNA 
coding for the 5 ’ -end of the SFV 26 S RNA has 
been positioned in a simian virus (SV40) cloning 
vector so that it is transcribed intracellularly as a 
part of the major late SV40 mRNA. Two different 
26 S cDNA fragments, both extending beyond the 
3’-end of the capsid gene, were transcribed, 
translated and cleaved into a capsid protein in- 
distinguishable in size from its natural counterpart 
synthesized uring SFV infections. 
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2. MATERIALS AND METHODS 
2.1. Cells and viruses 
SV40 and mixed SV40 recombinant virus stocks 
(raised after DNA transfection) were cultivated in 
CV-1 cells as described [13,14]. 
2.2. Bacteria and plasmids 
Escherichia coli HB 101 was used as a host for 
all plasmid propagations. The plasmid pBR322 
was used as a bacterial vector in the subclonings. 
The SFV 26 S cDNA was recovered from a clone 
in the plasmid pBR322 [15]. SV40 DNA 
(Boehringer-Mannheim) was cloned into the 
BamHI site of pBR322 prior to further construc- 
tions and the plasmid ptsA58Bam (hybrid of 
pBR322 and SV40 tsA58 DNA) was kindly provi- 
ded by Professor Sherman Weissmann. All 
plasmids were purified as in [161. 
2.3. Construction of recombinant DNA molecules 
The restriction enzyme fragments were made 
blunt-ended by a fill-in reaction and the linkers 
were ligated as described [14]. The 26 S cDNA 
fragments with appropriate linkers were ligated in- 
to the plasmid pBR322 and transformed into E. 
coli HB 101. The colonies containing 26 S cDNA 
were selected by colony hybridization [17]. 
Plasmid DNAs containing the desired 26 S cDNA 
fragments were isolated [14] and their 
ClaI/BamHI fragments inserted into the SV40 vec- 
tor. The SV40 recombinant DNAs were pro- 
pagated in E. coli after ligation to the BamHI site 
of pBR322. Transfection of recombinant DNAs 
into CV-1 cells was performed as in [14,18]. 
2.4. Analysis of RNA and proteins 
The cytoplasmic RNA was isolated from the 
recombinant and tsA58 infected CV-1 cells 48 h 
post-infection and poly(A)-containing RNA 
molecules were selected by oligo(dT)-cellulose 
chromatography [19]. Analysis of glyoxalated 
RNAs on 1 °70 agarose gels, transfer of the RNAs to 
nitrocellulose filter and filter hybridization with 
nick-translated 26 S cDNA probe (0.5 × 
106 cpm/ml of hybridization buffer) was done 
essentially as described by Thomas [201. 
For immunofluorescence staining the infected 
cells were fixed with 307o paraformaldehyde and 
permeabilized with 0.0507o Triton X-100. Indirect 
immunofluorescence staining was used (hamster T- 
antiserum for SV40 and rabbit anti-SFV capsid 
serum for the capsid protein) [14]. The recombi- 
nant virus stock titers were determined as im- 
munofluorescence units (IFU) for T-antigen. 
CV-1 cells (5 x 106) were infected with the 
recombinant virus and labelled with 50/zCi/ml of 
[35S]methionine 48 h post-infection i methionine- 
free modified Eagles medium (MEM) for 5 h. Im- 
munoprecipitation of the solubilized cells with 
anti-SFV nucleocapsid serum (diluted 1:100) was 
carried out as described [21]. The samples were 
then treated with electrophoresis buffer and 5 x 
10 4 cpm of the supernatants were analyzed by SDS 
gel electrophoresis [22]. 
3. RESULTS AND DISCUSSION 
3.1. Construction of SV40 recombinants expres- 
sing Semliki Forest virus capsid protein 
For expressing the SFV capsid protein in mam- 
malian cells, two different SV40 recombinants, 
svCI and svCII, were constructed from the 
5'-region of the 26 S cDNA. 
svCI: The 26 S cDNA was cleaved with EcoRI 
and the 1356 bp fragment containing the whole 
capsid and E3 genes, as well as 325 bp of the E2 
gene, was isolated. BamHI and ClaI linkers were 
ligated together into the fragment hat had been 
made blunt-ended by a fill-in reaction with reverse 
transcriptase. After subcloning in pBR322, the 
clone having the ClaI linker at the 5'-end and the 
BamHI linker at the 3'-end of the 26 S cDNA 
fragment was chosen. The fragment was inserted 
into SV40 late region between the HpalI and 
BamHI sites to form the construction svCI (fig. 1). 
svCII: The 26 S cDNA was cleaved with EcoRI, 
made blunt-ended whereafter a HindlII linker was 
added by ligation. This fragment was cleaved with 
XhoI and BamHI linkers were added. The 948 bp 
fragment containing the whole capsid gene and 
115 bp of the E3 gene was subcloned in pBR322. 
The 26 S fragment was cleaved from the vector 
with ClaI and BamHI and inserted into the SV40 
late region between the HpaI and BamHI sites 
(fig.l). The SV40 recombinant svCII obtained 
5 bp of pBR322 sequences (the ClaI-HindlII frag- 
ment) in addition to the 26 S specific insert. 
Both SV40 recombinants were then ligated to the 
BamHI site of pBR 322 for DNA production in E. 
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Fig.l. Schematic representation f the construction of 
the SV40 recombinants svCI and svCII. The Semliki 
Forest virus (SFV) 26 S cDNA EcoRI fragment (I, 
1356 bp), with ClaI and BamHI linkers, was inserted 
into the SV40 late region between the HpaII and BamHI 
sites to obtain the recombinant svCI. The 26 S cDNA 
EcoRI-XhoI fragment (II, 948 bp), with the ends altered 
to ClaI and BamHI, respectively, was inserted between 
the HpaII and BamHI sites of SV40 late region to obtain 
the construction svCII. The solid black line in the 
recombinant circles represents SV40 sequences with the 
early region on the left side, the white bar SFV capsid 
gene and the small hatched bars E3 and E2 sequences, 
respectively. The stippled arrow points to the major 
5'-end of the SV40 late RNAs, the solid arrow at the 
SV40 late polyadenylation site, and the arrowhead at the 
translation initiation codon at he capsid protein. 
coli. The DNA constructions svCI and svCII are 
located in the SV40 late region replacing almost the 
whole coding sequence. They contain in frame 
50 bp of the SV40 coding sequence downstream 
from the BamHI cloning site. Both svC recom- 
binants use the SV40 late promoter and 
polyadenylation signals, but lack the splice sites 
from the SV40 late region. 
3.2. Transfection of the SV40-SFV capsid 
recombinants into CV-1 cells 
The pBR322-svCI and pBR322-svCII recombi- 
nant DNAs were cleaved with BamHI and 
religated to remove the pBR322 sequences. The 
DNA was then transfected into CV-I cells together 
with the DNA of a SV40 early region mutant 
tsA58. Recombinant virus was collected 14 days 
after transfection and passaged 3 times in CV-I 
cells to obtain a virus stock of about 5 × 
106 IFU/ml.  
Following infection with the virus stocks raised 
from svCI and svCII, about 5070 of the ceils (cor- 
responding to a titer of 1 × 105 IFU/ml) expressed 
SFV capsid protein 48-72 h post-infection, as 
measured by immunofluorescence staining with 
SFV capsid antiserum. However, the SV40 T- 
antigen titers were about 5 x 106 IFU/ml  for both 
stocks, suggesting that they contained much more 
of  the tsA mutant han svC recombinant. This was 
also evident from analyses of the low-Mr DNA 
supernatants from Hirt extractions [23] by agarose 
gel electrophoresis. 
Most of the DNA was found to be the tsA58 
DNA (not shown). The restriction enzyme patterns 
of the two recombinant virus DNAs showed that 
the inserted 26 S cDNA fragments had retained the 
original structure. If  the capsid protein actually in- 
hibits host cell protein synthesis, as has been sug- 
gested [9-11], the poor production of the recombi- 
nant capsid protein is the expected result. Surpris- 
ingly, one of the svCII stocks (obtained from an 
independent transfection) yielded 70°70 of the in- 
fected cells capsid positive (corresponding to 1.4 x 
106 IFU/ml).  Whether this exceptionally good cap- 
sid producer recombinant perhaps contains a 
mutated capsid gene is an open question at present. 
3.3. Expression of SFV specific RNA 
Cytoplasmic poly(A)-containing mRNA 
molecules were isolated 48 h after infection of 
CV-I cells with the recombinant virus stocks at a 
multiplicity of infection of 3-5 IFU/cell. Glyox- 
alated RNAs were separated on 1 °70 agarose gels, 
transferred to nitrocellulose filter and hybridized 
with a 3ZP-labelled pKTH 1003 DNA probe (con- 
taining the SFV 26 S cDNA in the pBR322 vector). 
As shown in fig.2, RNAs of 12.1 kb from svCI and 
1.6 kb from svCII could be detected. A faint band 
at about 6 kb may represent contaminating DNA. 
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ABCD Fig.2. Northern blot analysis of RNA from svCI (A) and 
SVCII (B,D) infected CV-1 cells. Poly(A)-containing 
cytoplasmic RNA was isolated, treated with glyoxal and 
electrophoresed on a 1% agarose gel, The RNAs were 
blotted to nitrocellulose filter and hybridized against 
nick-translated pKTH 1003 probe (plasmid pkTH 1003 
contains the SFV 26 S cDNA in the pBR322 vector). The 
specific activity of the probe was 3.5 x 10’ cpm/pg. (C) 
Cytoplasmic RNA from SV40 infected cells. The 
exposure time for lanes A-C was 3 d, D is the same as 
B but the exposure time was 12 h. The figure also 
demonstrates the striking difference in expression levels 
between the svCI stock compared to the efficiently -4.7 
il) -1.9 
replicating svCI1 stock. 
3.4. intra~ei~uIar location of the recombinant 
SFV capsid proteins 
Indirect immunoff uorescence staining with SFV 
capsid antiserum was performed 48 h after infec- 
tion of CV-1 cells with the SV40 recombinant 
virus. As shown in fig.3, the SFV capsid protein 
produced was mainly accumulating in the nucleus. 
In normal SFV infections the capsid protein rapid- 
ly forms nucleocapsids with the viral 42 S RNA 
genome and is not detectable as a free protein 1241. 
Fig.3. Immunofluorescence staining of CV-1 cells for SFV capsid protein produced by the SV40 recombinants. Indirect 
immunofluorescence staining for SFV capsid protein was performed 48 h post svCI1 recombinant virus infection (A) 
or 7 h post SFV infection (B). Capsid protein produced by the svC recombinant is located in the nucleus, in contrast 
to SFV infection where the fluorescence can be seen mainly in the cytoplasm. In SV40 infected cells (C) no SFV capsid 
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Here, where the SFV capsid protein is lacking its 
normal acceptor, it seems to be transported into 
the cell nucleus. It has recently been reported that 
there are defined sequence requirements for 
nuclear location of proteins [25,26]. SFV capsid 
protein has many clusters of basic amino acids 
lysine and arginine, typical for such ‘transport 
signals’, and one of these sequences may form a 
structural feature that allows the capsid protein to 
be transported into the nucleus. The biological 
significance of this finding is unclear at present. 
-44.360 
Fig.4. Analysis of SFV capsid proteins produced by the 
SV40 recombinants. CV-1 cells were infected with the 
recombinant virus and labelled with [35S]methionine 
48 h post-infection. The SFV capsid proteins were 
immunoprecipitated from the cell lysate with specific 
SFV capsid antiserum and electrophoresed on 
polyacrylamide gradient gels. Both capsid recombinants 
svCI (B) and svCI1 (C) yielded a 30 kDa protein 
corresponding to the immunoprecipitated SFV capsid 
protein (D). SV40 infected cells were used as a negative 
control (A). 
3.5. Processing of the recombinant SFV capsid 
protein 
CV-1 cells infected with the SVC recombinants 
were analyzed for the sizes of the produced capsid 
polypeptides . SDS-polyacrylamide gel elec- 
trophoresis of the [35S]methionine-labelled and im- 
munoprecipitated capsid proteins showed that 
both recombinants yielded a labelled band of A4, 
30000 equivalent in size to the SFV capsid protein 
(fig.4). A protein, which also can be seen in lane A 
representing the SV40 wild type-infected cells, is 
apparently nonspecifically bound to the antibody 
or to protein A-Sepharose. The SV40 control 
showed no band comigrating with the SFV capsid 
protein. If proteolytic processing of the recombi- 
nant gene products did not occur, the expected 
sizes of the fusion proteins would have been ap- 
prox. 52 kDa (svC1) and 36 kDa (svCI1). Products 
of these sizes would clearly have been separated 
from the 30 kDa band on the gels. 
It has been previously suggested, based on in 
vitro translation studies with ts mutants [8], that 
the proteolytic cleavage of the capsid protein 
precursor may not be a host function. Here, in the 
absence of other SFV functions the capsid protein 
is still cleaved. 
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